Hisahiko Iwamoto

Title: Hisahiko Iwamoto: Innovator in Immunological Research

Introduction

Hisahiko Iwamoto is a prominent inventor based in Hiratsuka, Japan. He has made significant contributions to the field of immunology, holding a total of 11 patents. His work focuses on developing innovative solutions for diagnosing and treating various infections.

Latest Patents

One of Hisahiko Iwamoto's latest patents is a monoclonal antibody against IgM and a non-specific reaction inhibitor. The objective of this invention is to provide a monoclonal antibody capable of sufficiently inhibiting non-specific reactions caused by non-specific factors. This invention includes a non-specific reaction inhibitor containing the monoclonal antibody and relates to a monoclonal antibody against dog IgM produced by a hybridoma with accession No. NITE BP-02556. Another significant patent is for an anti-varicella-zoster virus antibody, along with an immunological measurement method and device. This invention aims to provide a means for rapidly diagnosing infection with the varicella-zoster virus (VZV). It includes an antibody against VZVgE or an antibody fragment, as well as methods and devices for immunological measurement using these antibodies.

Career Highlights

Throughout his career, Hisahiko Iwamoto has worked with notable companies such as Tanaka Kikinzoku Kogyo Co., Ltd. and Alferesa Pharma Corporation. His experience in these organizations has contributed to his expertise in immunological research and development.

Collaborations

Hisahiko Iwamoto has collaborated with talented individuals in his field, including Keita Suzuki and Yuya Kato. These collaborations have likely enhanced his research and innovation efforts.

Conclusion

Hisahiko Iwamoto is a distinguished inventor whose work in immunology has led to significant advancements in the diagnosis and treatment of infections. His contributions through his patents reflect his commitment to improving healthcare solutions.